NeraCare GmbH
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer.
NeraCare GmbH has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Frankfurt, Germany; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€0
€0
Funding rounds
1
Investors
2
distinct backers
Active since
2020-05
latest 2020-05
Funding by year
EUR raised per yearNeraCare GmbH — funding by year — interactive chart.
Data table
| NeraCare GmbH — funding by year | |
|---|---|
| 2020 | €0 |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-03 | Other | €0 | BayBG Bayerische Beteiligungsgesellschaft mbH,MIG Verwaltungs AG | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData